| Stem Cell Research and Therapy |
1 |
1 |
| Multiple Sclerosis |
0 |
0.99 |
| Transplantation |
0 |
0.98 |
| Biologic Therapy |
0 |
0.68 |
| Disability |
0 |
0.63 |
| Cell Transplantation |
0 |
0.97 |
| Bone Marrow Transplant |
0 |
0.5 |
| Secondary Progressive Multiple Sclerosis |
0 |
0.96 |
| Hand Transplantation |
0 |
0.42 |
| Bone Marrow |
0 |
0.14 |
| Brain |
0 |
0.13 |
| Immunotherapy |
0 |
0.13 |
| Blood-Brain Barrier |
0 |
0.12 |
| Bone |
0 |
0.1 |
| Match |
0 |
0.1 |
| Medical Life |
0 |
0.1 |
| Cerebrospinal Fluid |
0 |
0.09 |
| Blood |
0 |
0.03 |
| Central Nervous System |
0 |
0.03 |
| Europe |
0 |
0.03 |
| Fluid, Electrolyte, and Nutrition Management of the Newborn |
0 |
0.03 |
| Hand |
0 |
0.03 |
| Nutritional Support |
0 |
0.03 |
| Refractory |
0 |
0.03 |
| Relapsing Remitting Multiple Sclerosis |
0 |
0.03 |